A61K 47/60
The organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer
Official title: the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
A61K47/60 (The organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer) appears on 4,201 US grants and 6,893 published applications in this corpus.
Search patents in A61K- Granted patents
- 4,201
- Published applications
- 6,893
- Assignees
- 2,111
- Inventors
- 10,185
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 2 | 0 |
| 1978 | 1 | 0 |
| 1979 | 1 | 0 |
| 1980 | 0 | 0 |
| 1981 | 4 | 0 |
| 1982 | 0 | 0 |
| 1983 | 3 | 0 |
| 1984 | 0 | 0 |
| 1985 | 1 | 0 |
| 1986 | 1 | 0 |
| 1987 | 3 | 0 |
| 1988 | 5 | 0 |
| 1989 | 2 | 0 |
| 1990 | 12 | 0 |
| 1991 | 3 | 0 |
| 1992 | 13 | 0 |
| 1993 | 11 | 0 |
| 1994 | 20 | 0 |
| 1995 | 18 | 0 |
| 1996 | 26 | 0 |
| 1997 | 40 | 0 |
| 1998 | 36 | 0 |
| 1999 | 40 | 0 |
| 2000 | 27 | 0 |
| 2001 | 33 | 18 |
| 2002 | 51 | 71 |
| 2003 | 59 | 149 |
| 2004 | 40 | 142 |
| 2005 | 49 | 167 |
| 2006 | 72 | 174 |
| 2007 | 71 | 176 |
| 2008 | 73 | 219 |
| 2009 | 94 | 200 |
| 2010 | 128 | 290 |
| 2011 | 133 | 287 |
| 2012 | 142 | 267 |
| 2013 | 198 | 312 |
| 2014 | 228 | 349 |
| 2015 | 237 | 361 |
| 2016 | 243 | 396 |
| 2017 | 238 | 348 |
| 2018 | 255 | 335 |
| 2019 | 258 | 384 |
| 2020 | 219 | 330 |
| 2021 | 237 | 371 |
| 2022 | 198 | 371 |
| 2023 | 186 | 356 |
| 2024 | 192 | 344 |
| 2025 | 183 | 291 |
| 2026 | 113 | 185 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Therapeutic carbon nanomaterial H2S oxidants for biological polysulfide synthesis6 Oct 2026US 12,752,017 B2The Texas A&M University System
- Antitumor pharmaceutical composition and use thereof29 Sep 2026US 12,746,289 B2Jenkem Technology Co., Ltd. (Tianjin)
- Methods of loading extracellular vesicles29 Sep 2026US 12,746,291 B2Lonza Sales AG
- Biased IL2 muteins methods and compositions15 Sep 2026US 12,734,215 B2Synthekine, Inc.
- Processes of preparing mRNA-loaded lipid nanoparticles15 Sep 2026US 12,734,253 B2Translate Bio, Inc.
- Human interleukin-2 variant or derivative thereof8 Oct 2026US 2026/0308220 A1Jiangsu Hengrui Medicine Co., Ltd.
- Targeted engineered interferon and uses thereof8 Oct 2026US 2026/0308221 A1Orionis Biosciences BV
- Glucagon-like peptide-1 receptor agonist variants and methods thereof1 Oct 2026US 2026/0295054 A1
- Glp-1r/gipr/gcgr triple agonist analogue and use thereof1 Oct 2026US 2026/0295055 A1Shenzhen Bay Laboratory
- Three-arm polyethylene glycol derivative containing amino acid residues1 Oct 2026US 2026/0295057 A1Xiamen Sinopeg Biotech Co., Ltd.
Most cited
By later US patents
- Non-immunogenic polypeptides2,007US 4,179,337 A1979
- Uncharged morpolino-based polymers having phosphorous containing chiral intersubunit linkages851US 5,185,444 AAnti-Gene Deveopment Group · 1993
- Multiarmed, monofunctional, polymer for coupling to molecules and surfaces813US 5,932,462 AShearwater Polymers, Inc. · 1999
- Collagen-polymer conjugates778US 5,162,430 ACollagen Corporation · 1992
- Plasminogen activator derivatives616US 4,640,835 ANippon Chemiphar Co., Ltd. · 1987